FDA Finalizes Guidance on Weight-Loss Devices
The FDA has finalized guidance on premarket submission requirements for weight loss medical devices, covering non-clinical testing, clinical study design, and benefit-risk analysis. Developers of intragastric implants, aspiration therapy systems, and neuromodulators will want to review the agency's recommendations closely.
The post FDA Finalizes Guidance on Weight-Loss Devices appeared first on In Compliance Magazine.